Application and Nursing Care of Mid-Length Catheters in the Infusion of Oxaliplatin in Gastrointestinal Tumor Patients Refusing Central Venous Catheterization
Download PDF

Keywords

Medium-length catheter
Gastrointestinal tumor
Nursing
Complications

DOI

10.26689/otd.v3i4.13383

Submitted : 2025-12-09
Accepted : 2025-12-24
Published : 2026-01-08

Abstract

Objective: To investigate the application effectiveness and nursing care of mid-length catheters (MCs) in the infusion of oxaliplatin in gastrointestinal tumor patients who refuse central venous catheterization. Methods: A total of 71 patients with gastrointestinal tumors who were treated in our hospital from August 2024 to June 2025 were selected. All of them refused central venous catheterization due to subjective willingness and voluntarily accepted MC insertion for oxaliplatin chemotherapy. The MC insertion status of the patients was recorded, and the incidence of catheter-related complications during chemotherapy and the quality of life before and after intervention were observed. Results: The catheterization success rate among the 71 patients was 97.18%; the average catheterization time was (18.25 ± 1.12) minutes, and the average catheter indwelling time was (12.64 ± 4.58) days; a total of 5 catheter-related complications occurred during chemotherapy, with an overall incidence rate of 7.04%, all of which were mild to moderate complications, and no severe complications occurred; the quality of life score after intervention was significantly higher than that before intervention (P < 0.05). Conclusion: The application of mid-length catheters in the infusion of oxaliplatin in gastrointestinal tumor patients who refuse central venous catheterization offers advantages such as a high catheterization success rate, long indwelling time, low complication rate, and improved quality of life for patients. Combined with targeted nursing measures, it can further ensure medication safety.

References

Zhang X, Shan H, Zhu Z, 2025, Efficacy and Safety of Oxaliplatin and Capecitabine Combined with Sintilimab as First-line Treatment for HER2-negative Advanced Gastric Cancer. Chinese Clinical Research, 38(1): 37–41.

Liang Q, Yang L, Zhou Y, et al., 2023, Analysis of the Current Status and Influencing Factors of Kinesiophobia in Tumor Patients with PICC Catheterization. Journal of Nursing Science, 38(6): 59–62.

Wang L, Huang S, Chen J, et al., 2023, Analysis of Risk Factors for Central Venous Catheter-related Infections in Patients with Malignant Tumors Undergoing Chemotherapy. Chinese Journal of Nosocomiology, 33(19): 3029–3032.

Liu C, Liu F, Yao Q, et al., 2024, Analysis of Risk Factors and Preventive Strategies for Venous Thrombosis during Indwelling Medium-length Catheters in Elderly Critically Ill Patients in the ICU. Geriatrics & Health Care, 30(6): 1813–1817.

Zhang W, Wang C, Lu X, et al., 2024, Risk Factors for Peripheral Intravenous Catheter-induced Central Venous Catheter-related Venous Thrombosis in Elderly Patients with Gastrointestinal Tumors. Chinese Journal of Multiple Organ Diseases in the Elderly, 23(9): 690–693.

Wang X, Chen J, Zhang H, 2024, Analysis of Influencing Factors on the Status of Medium-length Intravenous Catheter-related Thrombosis in Patients with Malignant Tumors. Hebei Medical Journal, 46(23): 3652–3656.

Chen S, Zhao L, Yang X, et al., 2023, Observation on the Application Effect of Medium-length Intravenous Catheters in Patients Undergoing Weight Loss Surgery. Journal of Nurses Training, 38(23): 2176–2179.

Wang R, Chen W, Xiang M, 2025, Analysis of Risk Factors for Venous Thrombosis Caused by Medium-length Catheters Inserted via Peripheral Veins in Critically Ill Patients. Chinese Journal of Postgraduates of Medicine, 48(4): 361–364.

Sheng W, Wang R, Zhao Y, et al., 2025, Meta-analysis of the Application Effects of Different Tip Positions of Medium-length Intravenous Catheters. Chinese Journal of Nursing, 60(8): 990–997.

Li X, Yan F, Xu J, et al., 2024, Application Effect of Ultrasound-guided Medium-length Catheter Indwelling in Intravenous Infusion for Critically Ill Patients in Neurosurgery. Chongqing Medicine, 53(S01): 309–311.